Report Content
Chapter 1 Methodology and Scope
1.1 Market scope and definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates and calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 Synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of erectile dysfunction
3.2.1.2 Technological advancement in drug delivery systems
3.2.1.3 Increasing aging population
3.2.2 Industry pitfalls and challenges
3.2.2.1 Side effects and safety concerns
3.2.2.2 Stringent regulatory scenario
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Gap analysis
3.6 Pipeline analysis
3.7 Porter’s analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2024
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Drug, 2021 – 2034 ($ Mn)
5.1 Key trends
5.2 Viagra (Sildenafil Citrate)
5.3 Cialis (Tadalafil)
5.4 Levitra/Staxyn (Vardenafil)
5.5 Stendra/Spedra (Avanafil)
5.6 Zydena (Udenafil)
5.7 Other drugs
Chapter 6 Market Estimates and Forecast, By Route of Administration, 2021 – 2034 ($ Mn)
6.1 Key trends
6.2 Oral
6.3 Parenteral
6.4 Other routes of administration
Chapter 7 Market Estimates and Forecast, By Distribution Channel, 2021 – 2034 ($ Mn)
7.1 Key trends
7.2 Hospital pharmacies
7.3 Retail pharmacies
7.4 Online pharmacies
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.4 Asia Pacific
8.4.1 China
8.4.2 India
8.4.3 Japan
8.4.4 Australia
8.4.5 South Korea
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.6 Middle East and Africa
8.6.1 Saudi Arabia
8.6.2 South Africa
8.6.3 UAE
Chapter 9 Company Profiles
9.1 Bayer
9.2 Eli Lilly and Company
9.3 Endo
9.4 Futura Medical
9.5 Hims & Hers Health
9.6 Lupin
9.7 Meda Pharmaceuticals
9.8 Petros Pharmaceuticals
9.9 Pfizer
9.10 Sandoz
9.11 Simple Pharma
9.12 Sun Pharmaceutical Industries
9.13 Teva Pharmaceutical Industries
9.14 Zydus Lifesciences
